Video endoscopic inguinal lymphadenectomy for penile cancer
Monday, 18 August 2008 - Radical lymphadenectomy improves survival in penile cancer patients, but the morbidity of the classic open procedure exceeds 50%. Tobias-Machado et al. (2008) reported the updated results of Video Endoscopic Inguinal Lymphadenectomy (VEIL), an original minimally invasive procedure recently...
Authors: Tobias-Machado et al.
Sexual dysfunction in partners of men with premature ejaculation
Sunday, 17 August 2008 - Research in partners of men with erectile dysfunction suggests that a woman's sexual difficulties can be contingent on her partner's sexual dysfunction. However, little research has been conducted in partners of men with other sexual dysfunctions, such as premature ejaculation (PE). Hobbs et...
Authors: Hobbs et al.
Lower urinary tract symptoms and risk of prostate cancer
Sunday, 17 August 2008 - Screening for early prostate cancer is frequently employed in the routine management of men with lower urinary tract symptoms (LUTS), but the evidence-base linking LUTS with prostate cancer is limited.
Martin et al. (2008) assessed the association of LUTS with a subsequent prostate...
Authors: Martin et al.
Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer
Sunday, 17 August 2008 - Chemotherapy is emerging in the management of advanced penile cancer. Pizzocaro et al. (2008) evaluated the therapeutic activity of taxanes (T) in combination with cisplatin-fluorouracil (PF) for salvage of primarily unresectable or relapsed nodal metastases from squamous cell carcinoma (SCC)...
Authors: Pizzocaro et al.
Peyronie's disease: a critical appraisal of current diagnosis and treatment
Saturday, 16 August 2008 - Peyronie's disease is a fibrotic disorder of the tunica albuginea of the penis resulting in varying degrees of penile curvature and sexual dysfunction. In a review, Smith et al. (2008) discussed the diagnosis and treatment for Peyronie's disease.
Diagnosis of the disorder is made by...
Authors: Smith et al.
Anticholinergic drugs, bladder retraining and their combination for urge urinary incontinence
Saturday, 16 August 2008 - Lauti et al. (2008) compared bladder retraining and anticholinergic drugs in women with urge urinary incontinence.
Women with urge urinary incontinence were recruited by advertisements, from primary care and from a urogynaecology clinic. Women were randomised using a web page to bladder...
Authors: Lauti et al.
Durable complete response to frontline docetaxel in an advanced prostate cancer patient
Friday, 15 August 2008 - Docetaxel is currently indicated for androgen-independent, metastatic prostate cancer; there is also evidence demonstrating the role of CYP1B1 in modulating the activity of the drug. Brandi et al. (2008) presented the case of a man with residual disease after radical prostatectomy treated...
Authors: Brandi et al.
Review of transobturator and retropubic tape procedures for stress urinary incontinence
Friday, 15 August 2008 - Recently, various types of tension free vaginal tapes via retropubic and transobturator route (inside-out technique; outside-in technique) have been adopted for treatment of stress urinary incontinence. In a review, Latthe (2008) assessed the recent evidence on effectiveness and complications...
Authors: Latthe
ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer
Friday, 15 August 2008 - Prostate cancer is the most common male cancer in the Western world but is highly heterogeneous in disease progression and outcomes. Consequently, the most substantial morbidity may actually arise from the adverse psychosocial impact of distress in decision-making and long term quality of life...
Authors: Chambers et al.
Assessing outcomes in prostate cancer clinical trials: a twenty-first century Tower of Babel
Friday, 15 August 2008 - Because of the bone distribution of prostate cancer metastases, progression is more readily identified than response in prostate cancer clinical trials. As a result, there is an increased focus on progression-free survival (PFS) as a phase 2 endpoint. PFS, however, is vulnerable to inter-study...
Authors: Gignac et al.
